Young Ho Jung

J.P. Morgan

Papers

1

Total Citations

5

H-Index

1

About

Young Ho Jung is a leading clinician-scientist whose work sits at the intersection of head and neck oncology and advanced imaging. His primary research focuses on the role of MRI in predicting surgical outcomes for human papillomavirus (HPV)-positive oropharyngeal cancers, particularly in the context of transoral robotic surgery (TORS). In his most cited study (2020, 5 citations), Jung demonstrated that preoperative MRI-based assessment of the pharyngeal constrictor muscle can serve as a reliable predictor of surgical margin status in HPV-positive tonsillar cancer. This finding is critical, as achieving clear margins is a key determinant of oncologic success and functional preservation in TORS. By identifying imaging biomarkers that guide surgical planning, Jung’s work helps refine patient selection and improve outcomes in a rapidly evolving treatment landscape. His contributions are especially timely given the rising incidence of HPV-positive head and neck cancers. Through this research, Jung has established himself as a key figure bridging radiology and surgical oncology, offering practical tools that directly impact clinical decision-making and patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
MRI-Based Assessment of the Pharyngeal Constrictor Muscle as a Predictor of Surgical Margin after Transoral Robotic Surgery in HPV-Positive Tonsillar Cancer
5 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: J.P. Morgan

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago